Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Übersicht 
Anne Michelle Clem Whitaker is an American businessperson who has been at the head of 9 different companies. Currently, she is Chairman for Aerami Therapeutics Holdings, Inc. and Chief Executive Officer & Director at Dance Biopharm Holdings, Inc., Chairman for Aerami Therapeutics, Inc. (a subsidiary of Dance Biopharm Holdings, Inc.). Ms. Whitaker is also Managing Partner at Anne Whitaker Group LLC and on the board of 7 other companies.

In her past career Ms. Whitaker held the position of President, Chief Executive Officer & Director at KNOW Bio LLC, President, Chief Executive Officer & Director at Novoclem Therapeutics, President-North America Pharmaceuticals at Sanofi and Chief Executive Officer for Sanofi US Services, Inc. (a subsidiary of Sanofi), Senior VP-Leadership & Organization Development at GlaxoSmithKline Plc and SVP, Head-Cardiovascular, Metabolic & Urology Unit at GlaxoSmithKline LLC (a subsidiary of GlaxoSmithKline Plc), Executive Vice President of Bausch Health Cos., Inc. Chairman & Executive Vice President at Salix Pharmaceuticals Ltd. and Chairman & Executive Vice President at Dendreon Corp. (both are subsidiaries of Bausch Health Cos., Inc.), President, Chief Executive Officer & Director at Synta Pharmaceuticals Corp., Metabolic Disease Specialist at The Upjohn Co., Principal at Delta Communications, Inc. and Vice Chairman for National Pharmaceutical Council.

She received an undergraduate degree from the University of North Alabama.


Aktuelle Stellungen und Verantwortungsbereiche Anne Michelle Clem Whitaker 
NameTitel Seit
UDG Healthcare plc
Independent Non-Executive Director 2020
OraSure Technologies, Inc.
(Medizinische Versorgung)
Independent Director 2021
Faron Pharmaceuticals Oy
(Biotechnologie)
Non-Executive Director 2021
Caladrius Biosciences, Inc.
(Biotechnologie)
Independent Director 2020
Mallinckrodt plc
(Pharmazeutika)
Independent Director 2018
Aerami Therapeutics Holdings, Inc. Chairman -
Dance Biopharm Holdings, Inc. Chief Executive Officer & Director 2018
University of North Alabama Trustee 2018
Aerami Therapeutics, Inc. Chairman 2020
Bryn Pharma LLC Director 2021
Anne Whitaker Group LLC Managing Partner 2018


Anteile an Anne Michelle Clem Whitaker 
NameAktien%Wert
Wolfspeed, Inc. (WOLF)
(Halbleiter )
11 2740,0097%1 260 095 USD
Caladrius Biosciences, Inc. (CLBS)
(Biotechnologie)
182 6350,31%153 779 USD
OraSure Technologies, Inc. (OSUR)
(Medizinische Versorgung)
10 5630,015%91 792 USD


Anne Michelle Clem Whitaker: Persönliches Netzwerk 
Meistgelesene News 
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
10.01.BRUNELLO CUCINELLI : Luxuskonzern Cucinelli verzeichnet 31% Umsatzplus im Jahr 2021
MR
07.01.CHRISTIAN KLEIN : Deutschlands Vorzeige-Tech-Konzern am Scheideweg
DP
07.01.TIM COOK : Apple-Chef Cook erhält für 2020 fast 100 Millionen Dollar
RE
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
10.01.PAUL SCHULER : Jahresumsatz von 9,15 Milliarden Franken erwartet
AW
10.01.Estelle Brachlianoff wird nächste CEO von Veolia
MR
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Anne Michelle Clem Whitaker : Verbindungen